GlassScriptPhysician profile
Nathan David Cass
NPI 1518385566
$4,752.71
in general payments reported to CMS, 2019-2025
6 companies · $2,679 in 2025
The $2,679 reported for 2025 was more than what 81% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $360 · 2023: $381 · 2024: $1,333 · 2025: $2,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,935 · Food and Beverage: $1,558 · Education: $500 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,934.70 |
| Food and Beverage | $1,558.01 |
| Education | $500.00 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,373.98 | 2025 | Core, Xpress Loprofile, N/A |
| Cochlear Americas | $1,160.06 | 2022-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Med-El Corporation | $861.17 | 2022-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Advanced Bionics, LLC | $155.39 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Depuy Synthes Sales INC. | $110.06 | 2022 | |
| Integra Lifesciences Corporation | $92.05 | 2024 | Microfrance, Codman Isocool Aht, Integra Duo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Cass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.